Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting

Ryoko Nakagawa,1 Takashi Ohnishi,1 Hisanori Kobayashi,1 Toshio Yamaoka,2 Tsutomu Yajima,3 Ai Tanimura,4 Toshiya Kato,4 Kazutake Yoshizawa1 1Evidence Generation Department, Medical Affairs Division, 2Clinical Data Management Department, R&D Division, 3Biostatistics Department, Quantitative S...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nakagawa R, Ohnishi T, Kobayashi H, Yamaoka T, Yajima T, Tanimura A, Kato T, Yoshizawa K
Format: article
Langue:EN
Publié: Dove Medical Press 2017
Sujets:
Alzheimer’s disease
cholinesterase inhibitor
cognitive function
disease progression
real-world evidence
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Accès en ligne:https://doaj.org/article/2a217dedb86f42edbf9cf8338e2e763a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Soyez le premier à ajouter un commentaire!
Il faut se connecter d'abord

Documents similaires